US FDA Chief Gottlieb Envisions Tiered Mandates For Opioid Training System
Executive Summary
Mandatory training could be reserved for physicians who want to prescribe opioids for longer-term use, as opposed to those who would prescribe recommended amounts in blister packs; evidence that blister packs would affect prescribing still is needed, however.
You may also be interested in...
US FDA Needs ‘More Streamlined’ REMS Enforcement Authority, Inspector General Says
Additional power would allow the agency to punish 'simple' REMS violations and improve administration of risk management programs, according to a new report looking at FDA's oversight of opioids.
Opioid Blister-Pack Mandate Tops Gottlieb's Agenda With New Authority
US FDA Commissioner says mandate for unit-of-dose packaging for opioids coming soon, but also acknowledges that move may make the drugs more expensive.
Opioid REMS Increases Nearly Six-Fold As US FDA Adds Immediate-Release Products
Basically every doctor prescribing any opioid is now covered by the REMS, but training remains voluntary.